Haolu Wang Selected Research

Ceramides

1/2021

C24-Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haolu Wang Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 02/2013
4	Liver Diseases (Liver Disease) 01/2021 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 03/2015
3	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021 - 02/2013
2	Carcinogenesis 01/2021 - 11/2018
2	Neoplasm Metastasis (Metastasis) 08/2020 - 07/2016
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2019
2	Klatskin Tumor 01/2017 - 01/2016
2	Reperfusion Injury 03/2015 - 01/2015
1	Trichinellosis 10/2023
1	Infections 10/2023
1	Cholestasis 01/2022
1	Sclerosing Cholangitis 01/2022
1	End Stage Liver Disease 08/2020
1	Disease Progression 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 07/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Carcinoma (Carcinomatosis) 11/2016
1	Postoperative Pain 03/2016
1	Inguinal Hernia (Direct Inguinal Hernia) 03/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Fibrosis (Cirrhosis) 03/2015
1	Ischemia 01/2015
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 01/2016
2	BismuthIBA 01/2017 - 01/2016
2	Glutathione (Reduced Glutathione)IBA 01/2016 - 02/2013
2	multidrug resistance-associated protein 1IBA 01/2016 - 02/2013
2	Coloring Agents (Dyes)IBA 03/2015 - 01/2015
1	AntigensIBA 10/2023
1	IntegrinsIBA 01/2023
1	phosphatidylinositol 5-phosphateIBA 01/2021
1	CeramidesIBA 01/2021
1	LipidsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	CarbonIBA 08/2020
1	phytochlorinIBA 08/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2020
1	Flavin-Adenine Dinucleotide (FAD)IBA 07/2020
1	NAD (NADH)IBA 07/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	alpha2 Subunit Collagen Type IIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	LigandsIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	GoldIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 11/2018
1	AntioxidantsIBA 11/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2018
1	Surface Antigens (Surface Antigen)IBA 07/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Emodin (Archin)IBA 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	Alanine Transaminase (SGPT)IBA 01/2015
1	Verapamil (Calan)FDA LinkGeneric 02/2013
1	PlatinumIBA 02/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2015
3	Liver Transplantation 03/2022 - 08/2020
3	Radiotherapy 01/2019 - 01/2017
3	Drug Therapy (Chemotherapy) 11/2018 - 02/2013
2	Precision Medicine 01/2019 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Photochemotherapy (Photodynamic Therapy) 08/2020
1	Photothermal Therapy 08/2020
1	Phototherapy (Light Therapy) 08/2020
1	Intravenous Injections 01/2019
1	Roux-en-Y Anastomosis (Anastomosis, Roux en Y) 11/2016
1	Lymph Node Excision (Lymph Node Dissection) 11/2016
1	Anesthesia 03/2016
1	Local Anesthesia 03/2016
1	Segmental Mastectomy (Lumpectomy) 01/2016